Literature DB >> 33728221

Actinotignum schaalii Caught for the Second Time in Fournier's Gangrene!

Syeda Sahra1, Abdullah Jahangir1, Harika Kandlakunta1, Allison Glaser2.   

Abstract

Actinotignum schaalii, a Gram-positive rod residing in the urinary tract, is responsible for urinary tract infections and their complications including but not limited to bacteremia and sepsis. A. schaalii is increasingly being detected in body fluid specimens owing to advancements in PCR techniques. This report describes an interesting case of an adult diabetic patient managed for Fournier's gangrene. A. schaalii was detected in the PCR of his wound cultures. To the best of our knowledge, this is the second case of A. schaalii as the causative agent for Fournier's gangrene.
Copyright © 2021, Sahra et al.

Entities:  

Keywords:  actinobaculum schaali; actinotignum schaali; fournier’s gangrene

Year:  2021        PMID: 33728221      PMCID: PMC7955795          DOI: 10.7759/cureus.13288

Source DB:  PubMed          Journal:  Cureus        ISSN: 2168-8184


  13 in total

1.  Characterization of some Actinomyces-like isolates from human clinical specimens: reclassification of Actinomyces suis (Soltys and Spratling) as Actinobaculum suis comb. nov. and description of Actinobaculum schaalii sp. nov.

Authors:  P A Lawson; E Falsen; E Akervall; P Vandamme; M D Collins
Journal:  Int J Syst Bacteriol       Date:  1997-07

2.  Actinobaculum schaalii causing Fournier's gangrene.

Authors:  Isabelle Vanden Bempt; Stefanie Van Trappen; Ilse Cleenwerck; Paul De Vos; Kim Camps; Annemie Celens; Martine Van De Vyvere
Journal:  J Clin Microbiol       Date:  2011-04-20       Impact factor: 5.948

3.  Actinobaculum schaalii as a uropathogen in immunocompromised hosts.

Authors:  Alireza Ghadian
Journal:  Iran J Kidney Dis       Date:  2012-09       Impact factor: 0.892

4.  Fournier's Gangrene: population based epidemiology and outcomes.

Authors:  Mathew D Sorensen; John N Krieger; Frederick P Rivara; Joshua A Broghammer; Matthew B Klein; Christopher D Mack; Hunter Wessells
Journal:  J Urol       Date:  2009-03-14       Impact factor: 7.450

5.  Actinobaculum schaalii: a common cause of urinary tract infection in the elderly population. Bacteriological and clinical characteristics.

Authors:  Hans Linde Nielsen; Karen Marie Søby; Jens Jørgen Christensen; Jørgen Prag
Journal:  Scand J Infect Dis       Date:  2010

6.  New insights into the epidemiology and etiology of Fournier's gangrene: a review of 33 patients.

Authors:  R Czymek; P Hildebrand; M Kleemann; U Roblick; M Hoffmann; T Jungbluth; C Bürk; H-P Bruch; P Kujath
Journal:  Infection       Date:  2009-07-23       Impact factor: 3.553

7.  Pyelonephritis caused by Actinobaculum schaalii in a child with pyeloureteral junction obstruction.

Authors:  D Pajkrt; A M Simoons-Smit; P H M Savelkoul; J van den Hoek; W W M Hack; A M van Furth
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-06-17       Impact factor: 3.267

Review 8.  Vertebral osteomyelitis caused by Actinobaculum schaalii: a difficult-to-diagnose and potentially invasive uropathogen.

Authors:  P Haller; T Bruderer; S Schaeren; G Laifer; R Frei; M Battegay; U Flückiger; S Bassetti
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2007-09       Impact factor: 3.267

9.  Endocarditis caused by Actinobaculum schaalii, Austria.

Authors:  Martin Hoenigl; Eva Leitner; Thomas Valentin; Gernot Zarfel; Helmut J F Salzer; Robert Krause; Andrea J Grisold
Journal:  Emerg Infect Dis       Date:  2010-07       Impact factor: 6.883

10.  Actinobaculum schaalii, a common uropathogen in elderly patients, Denmark.

Authors:  Steffen Bank; Anders Jensen; Thomas M Hansen; Karen M Søby; Jørgen Prag
Journal:  Emerg Infect Dis       Date:  2010-01       Impact factor: 6.883

View more
  1 in total

1.  Management of Fournier's gangrene during the Covid-19 pandemic era: make a virtue out of necessity.

Authors:  Alessio Paladini; Giovanni Cochetti; Angelica Tancredi; Matteo Mearini; Andrea Vitale; Francesca Pastore; Paolo Mangione; Ettore Mearini
Journal:  Basic Clin Androl       Date:  2022-07-19
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.